Clinical Trial Update: PSMA PET/CT for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on PSMA PET/CT for prostate cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED